Hi %%First name%%, Patient clinical design input can reduce the burden, improve retention and increase efficiency. Such significant gains should be captured with smarter involvement of patient feedback. To help you incorporate patient input from the outset, we have senior leaders Craig Lipset, Head of Clinical Innovation at Pfizer and Faye O'Brien, Associate Director, Clinical Development at AstraZeneca ready to share their experiences live. Join us on March 30th at 3pm CET/2pm GMT (9am EST) for our online webinar to discuss how to: Understand what information patients require when determining trial design which also meets regulator concerns Rewrite protocols to ensure they are delivered to the patient in a language and terminology that resonates Engage patients in protocol studies to assess treatment options, risks, potential burdens and eligibility criteria Sign up here to ensure you don’t miss out Best, Hayley Head of Europe eyeforpharma Hdunn@eyeforpharma.com     Unsubscribe